lactic acid has been researched along with Coronary Artery Stenosis in 16 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, hemodynamics, transmural high-energy phosphate (HEP), 2-deoxyglucose-6-phosphate (2-DGP) levels, and myocardial blood flow (MBF) were determined under basal conditions, during dobutamine infusion (DOB: 20 microg x kg(-1) x min(-1) iv), and during coronary stenosis + DOB + 2-deoxyglucose (2-DG) infusion." | 3.74 | Transmural distribution of metabolic abnormalities and glycolytic activity during dobutamine-induced demand ischemia. ( Eijgelshoven, MH; Jameel, MN; Mansoor, A; Wang, X; Zhang, J, 2008) |
| " The primary endpoint was a composite of major adverse cardiac events (MACE) at 180+/-14 days and expected to be below 20%." | 2.74 | The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic). ( Agostoni, P; Birkemeyer, R; Grube, E; Haine, S; Haude, M; Jung, W; Müller, R; Sarno, G; van Langenhove, G; Verheye, S; Vrints, C; Wijns, W; Willems, T, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (62.50) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naghipoor, J | 1 |
| Rabczuk, T | 1 |
| Ali, MT | 1 |
| Martin, K | 1 |
| Kumar, AH | 1 |
| Cavallin, E | 1 |
| Pierrou, S | 1 |
| Gleeson, BM | 1 |
| McPheat, WL | 1 |
| Turner, EC | 1 |
| Huang, CL | 1 |
| Khider, W | 1 |
| Vaughan, C | 1 |
| Caplice, NM | 1 |
| Vesga, B | 1 |
| Hernandez, H | 1 |
| Moncada, M | 1 |
| Gasior, P | 1 |
| Higuera, S | 1 |
| Dager, A | 1 |
| Arana, C | 1 |
| Delgado, JA | 1 |
| Généreux, P | 1 |
| Maehara, A | 1 |
| Granada, JF | 1 |
| Koizumi, K | 1 |
| Shin, H | 1 |
| Matayoshi, T | 1 |
| Yozu, R | 1 |
| Wang, Y | 1 |
| Liu, XC | 1 |
| Zhao, J | 1 |
| Kong, XR | 1 |
| Shi, RF | 1 |
| Zhao, XB | 1 |
| Song, CX | 1 |
| Liu, TJ | 1 |
| Lu, F | 1 |
| Verheye, S | 1 |
| Sarno, G | 1 |
| Müller, R | 1 |
| Birkemeyer, R | 1 |
| Vrints, C | 1 |
| Jung, W | 1 |
| Agostoni, P | 1 |
| van Langenhove, G | 1 |
| Haine, S | 1 |
| Willems, T | 1 |
| Haude, M | 1 |
| Grube, E | 2 |
| Wijns, W | 1 |
| Rodriguez, AE | 1 |
| Vigo, CF | 1 |
| Delacasa, A | 1 |
| Mieres, J | 1 |
| Fernandez-Pereira, C | 1 |
| Bernardi, V | 1 |
| Bettinoti, M | 1 |
| Rodriguez-Granillo, AM | 1 |
| Rodriguez-Granillo, G | 1 |
| Santaera, O | 1 |
| Curotto, V | 1 |
| Rubilar, B | 1 |
| Tronge, J | 1 |
| Palacios, IF | 1 |
| Antoniucci, D | 1 |
| Kadota, K | 1 |
| Muramatsu, T | 1 |
| Iwabuchi, M | 1 |
| Saito, S | 1 |
| Hayashi, Y | 1 |
| Ikari, Y | 1 |
| Nanto, S | 1 |
| Fujii, K | 1 |
| Inoue, N | 1 |
| Namiki, A | 1 |
| Kimura, T | 1 |
| Mitsudo, K | 1 |
| Flege, C | 1 |
| Vogt, F | 1 |
| Höges, S | 1 |
| Jauer, L | 1 |
| Borinski, M | 1 |
| Schulte, VA | 1 |
| Hoffmann, R | 1 |
| Poprawe, R | 1 |
| Meiners, W | 1 |
| Jobmann, M | 1 |
| Wissenbach, K | 1 |
| Blindt, R | 1 |
| Fallavollita, JA | 1 |
| Malm, BJ | 1 |
| Canty, JM | 1 |
| Willigers, HM | 1 |
| Prinzen, FW | 1 |
| Roekaerts, PM | 1 |
| de Lange, S | 1 |
| Durieux, ME | 1 |
| Sonoda, S | 1 |
| Ikeno, F | 1 |
| Honda, Y | 1 |
| Kar, S | 1 |
| Chan, C | 1 |
| Gerckens, U | 1 |
| Lansky, AJ | 1 |
| Fitzgerald, PJ | 1 |
| Bhargava, B | 1 |
| Reddy, NK | 1 |
| Karthikeyan, G | 1 |
| Raju, R | 1 |
| Mishra, S | 1 |
| Singh, S | 1 |
| Waksman, R | 1 |
| Virmani, R | 1 |
| Somaraju, B | 1 |
| Sidi, A | 2 |
| Muehlschlegel, JD | 2 |
| Muehschlegel, JD | 1 |
| Kirby, DS | 2 |
| Lobato, EB | 2 |
| Jameel, MN | 1 |
| Wang, X | 1 |
| Eijgelshoven, MH | 1 |
| Mansoor, A | 1 |
| Zhang, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison Among a Paclitaxel Eluting Stent With Biodegradable Polymer Versus an Uncoated Bare Metal Stent. A Prospective, Multicentric and Randomized Study.(EUCATAX Trial)[NCT00825279] | Phase 4 | 300 participants (Actual) | Interventional | 2007-08-31 | Completed | ||
| Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction: a Double-Blind, Multicenter, Randomized, Placebo-Controlled Clinical Trial[NCT04912518] | 250 participants (Anticipated) | Interventional | 2021-05-27 | Recruiting | |||
| Prospective, Randomized Trial of 3 Rapamycin-Eluting Stents With Different Polymer Coating Strategies For The Reduction of Coronary Restenosis (ISAR-TEST-3)[NCT00350454] | Phase 4 | 605 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| Clinical and Angiographic Evaluation of Paclitaxel Eluting, Non-Polymeric, Nanoporous Carbon-Carbon Coated, Cobalt-Chromium Stent[NCT00428662] | 200 participants | Interventional | 2007-01-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for lactic acid and Coronary Artery Stenosis
| Article | Year |
|---|---|
The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic).
Topics: Aged; Angioplasty, Balloon, Coronary; Belgium; Cardiovascular Agents; Chromium Alloys; Coronary Angi | 2009 |
Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Argentina; Cardiovascular Agents; Chi-Square Distribution; Coa | 2011 |
Randomized comparison of the Nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries.
Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary | 2012 |
Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.
Topics: Aged; Anticoagulants; Catheterization; Cineangiography; Coated Materials, Biocompatible; Comorbidity | 2004 |
12 other studies available for lactic acid and Coronary Artery Stenosis
| Article | Year |
|---|---|
A mechanistic model for drug release from PLGA-based drug eluting stent: A computational study.
Topics: Computer Simulation; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Drug-Eluting Sten | 2017 |
A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammation.
Topics: Animals; Anti-Inflammatory Agents; Cell Proliferation; Coated Materials, Biocompatible; Coronary Ste | 2015 |
Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study.
Topics: Absorbable Implants; Acute Coronary Syndrome; Aged; Cardiovascular Agents; Chromium; Coronary Angiog | 2017 |
Comparison of active and passive coronary perfusion in off-pump coronary artery bypass grafting.
Topics: Animals; Coronary Artery Bypass, Off-Pump; Coronary Circulation; Coronary Stenosis; Disease Models, | 2008 |
Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization.
Topics: Angiogenesis Inducing Agents; Animals; Cell Proliferation; Coronary Circulation; Coronary Stenosis; | 2009 |
Development and characterization of a coronary polylactic acid stent prototype generated by selective laser melting.
Topics: Biocompatible Materials; Cells, Cultured; Chromatography, Gel; Coronary Stenosis; Humans; Lactic Aci | 2013 |
Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest.
Topics: Adaptation, Physiological; Adrenergic beta-Agonists; Animals; Blood Flow Velocity; Blood Pressure; C | 2003 |
Dexmedetomidine decreases perioperative myocardial lactate release in dogs.
Topics: Adrenergic alpha-Agonists; Animals; Catecholamines; Coronary Circulation; Coronary Stenosis; Depress | 2003 |
A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
Topics: Analysis of Variance; Animals; Carbon; Chromium; Coated Materials, Biocompatible; Cobalt; Coronary A | 2006 |
Treating metabolic impairment and myocardial stunning with phosphodiesterase inhibitor type III, milrinone, administered prior to coronary artery occlusion in the presence of calcium channel blockade in pigs.
Topics: Analysis of Variance; Animals; Biomarkers; Blood Pressure; Calcium Channel Blockers; Cardiac Output; | 2007 |
Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary S | 2008 |
Transmural distribution of metabolic abnormalities and glycolytic activity during dobutamine-induced demand ischemia.
Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Do | 2008 |